+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Active Wound Care Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2023-2030 - (By Product Coverage, Automation Coverage, End User Coverage, Geographic Coverage and By Company)

  • PDF Icon

    Report

  • 146 Pages
  • June 2024
  • Region: Global
  • Fairfield Market Research
  • ID: 5979809

The global active wound care market is poised for significant growth, with projections indicating a rise from US$10.5 billion in 2023 to US$14.9 billion by 2030. This expansion is driven by technological advancements, rising prevalence of chronic diseases, and increased adoption of sustainable practices in wound management.

Key Growth Determinants

Technological Intervention in the Wound Care Sector

Continuous technological innovation is a fundamental catalyst propelling the active wound care market. Advanced technologies, such as telemedicine applications, intelligent dressings, and connected wound care devices, are transforming wound management. These technologies facilitate individualized patient care and accelerate the healing process through real-time monitoring and continuous assessment.

The integration of Artificial Intelligence (AI) in wound assessment and treatment planning offers significant insights, enhancing patient outcomes and expanding the market. The adoption of state-of-the-art technologies in the wound care industry promises improved therapeutic results and more efficient healthcare procedures.

Rising Prevalence of Chronic Disorders

The global increase in chronic diseases, particularly diabetes and vascular disorders, significantly drives the demand for active wound care solutions. Chronic conditions often result in complex wounds, necessitating specialized and advanced wound care products. The market is responding with innovative solutions like growth factors and bioactive dressings that foster expedited recovery.

The aging population further amplifies the prevalence of chronic wounds, generating a sustained need for effective wound care interventions. This demographic trend underscores the importance of specialized products designed to address the unique healthcare needs of elderly patients.

Major Growth Barriers

Higher Investments

A significant barrier to the growth of the active wound care market is the high cost associated with advanced wound care products. Despite their effectiveness, the financial burden on healthcare systems and patients may impede widespread adoption, particularly in resource-limited settings.

Limited Availability

Restricted reimbursement policies for certain active wound care products pose another challenge. Limited coverage and reimbursement availability can hinder the broad adoption of advanced wound care treatments, affecting both healthcare providers and patients, and constraining the market’s potential for accessibility and utilization.

Key Trends and Opportunities to Look At

Increased Adoption of Telemedicine

The use of telemedicine in wound care is experiencing tremendous growth, driven by its efficiency and accessibility. Strategic alliances, such as those between Smith & Nephew and Teladoc Health, are enhancing remote wound monitoring capabilities. Telemedicine platforms facilitate remote consultations, real-time wound assessments, and seamless patient engagement, ensuring broad accessibility and personalized care.

Focus on Environmentally Favourable Solutions

There is a growing demand for sustainable wound care practices, reflecting a global shift towards eco-friendly healthcare solutions. Companies like Molnlycke Health Care are prioritizing the development of sustainable products, using energy-efficient manufacturing processes, environmentally friendly packaging, and biodegradable materials to align with consumer preferences and support environmentally conscious healthcare.

Technological Trends Like Smart Dressings

Innovative technologies, such as connected devices and intelligent dressings, are reshaping the wound care industry. Investments in research and development by companies like Smith & Nephew and 3M are leading to the creation of smart wound care solutions. These advancements use data-driven insights, cloud computing, and IoT integration to improve product efficacy, patient outcomes, and market competitiveness.

Regional Frontrunners

North America’s Leadership Prevails on the Back of Extensive Healthcare Spending

North America is poised to dominate the global active wound care market, driven by its well-established healthcare infrastructure, high rates of advanced technology adoption, and significant investments in research and development. The prevalence of chronic diseases and a growing elderly population further reinforce North America's leadership in the market.

Asia Pacific Attains the Status of a High-Potential Market

The Asia Pacific region is expected to experience the fastest growth in the global active wound care market. Factors contributing to this expansion include increasing awareness of advanced healthcare solutions, rising healthcare expenditures, and improved access to healthcare in developing economies. The prevalence of chronic diseases and an aging population are driving the demand for active wound care products, further supported by continuous advancements in healthcare infrastructure and innovative technologies.

Competitive Analysis

1. Smith & Nephew
2. MiMedx
3. Tissue Regenix
4. Organogenesis Inc.
5. Acell Inc.
6. Integra Life Sciences
7. Solsys Medical
8. Osiris Therapeutics Inc.
9. Cytori Therapeutics Inc.
10. Human BioSciences
11. Wright Medical Group N.V.

Global Active Wound Care Market is Segmented as Below:

By Product:

  • Skin Substitutes
  • Growth Factors
  • Biomaterials

By Automation:

  • Chronic Wounds
  • Acute Wounds

By End User:

  • Hospitals
  • Home Healthcare
  • Specialty Clinics
  • Others

By Geographic Coverage:

  • North America
  • S.
  • Canada
  • Europe
  • Germany
  • K.
  • France
  • Italy
  • Turkey
  • Russia
  • Rest of Europe
  • Asia Pacific
  • China
  • Japan
  • South Korea
  • India
  • Southeast Asia
  • Rest of Asia Pacific
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
  • Middle East & Africa
  • GCC
  • South Africa
  • Egypt
  • Nigeria
  • Rest of Middle East & Africa


This product will be delivered within 1-3 business days.

Table of Contents

1. Executive Summary
1.1. Global Active Wound Care Market Snapshot
1.2. Future Projections
1.3. Key Market Trends
1.4. Regional Snapshot, by Value, 2022
1.5. Analyst Recommendations
2. Market Overview
2.1. Market Definitions and Segmentations
2.2. Market Dynamics
2.2.1. Drivers
2.2.2. Restraints
2.2.3. Market Opportunities
2.3. Value Chain Analysis
2.4. Porter’s Five Forces Analysis
2.5. COVID-19 Impact Analysis
2.5.1. Supply
2.5.2. Demand
2.6. Impact of Ukraine-Russia Conflict
2.7. Economic Overview
2.7.1. World Economic Projections
2.8. PESTLE Analysis
3. Global Active Wound Care Market Outlook, 2018 - 2030
3.1. Global Active Wound Care Market Outlook, by Product, Value (US$ Mn), 2018 - 2030
3.1.1. Key Highlights
3.1.1.1. Skin Substitutes
3.1.1.2. Growth Factors
3.1.1.3. Biomaterials
3.2. Global Active Wound Care Market Outlook, by Application, Value (US$ Mn), 2018 - 2030
3.2.1. Key Highlights
3.2.1.1. Cancer
3.2.1.2. Immunology
3.2.1.3. Cardiovascular Diseases
3.3. Global Active Wound Care Market Outlook, by End User, Value (US$ Mn), 2018 - 2030
3.3.1. Key Highlights
3.3.1.1. Hospitals
3.3.1.2. Dental Clinics
3.3.1.3. Research Institutes
3.4. Global Active Wound Care Market Outlook, by Region, Value (US$ Mn), 2018 - 2030
3.4.1. Key Highlights
3.4.1.1. North America
3.4.1.2. Europe
3.4.1.3. Asia Pacific
3.4.1.4. Latin America
3.4.1.5. Middle East & Africa
4. North America Active Wound Care Market Outlook, 2018 - 2030
4.1. North America Active Wound Care Market Outlook, by Product, Value (US$ Mn), 2018 - 2030
4.1.1. Key Highlights
4.1.1.1. Skin Substitutes
4.1.1.2. Growth Factors
4.1.1.3. Biomaterials
4.2. North America Active Wound Care Market Outlook, by Application, Value (US$ Mn), 2018 - 2030
4.2.1. Key Highlights
4.2.1.1. Chronic Wounds
4.2.1.2. Acute Wounds
4.3. North America Active Wound Care Market Outlook, by End User, Value (US$ Mn), 2018 - 2030
4.3.1. Key Highlights
4.3.1.1. Hospitals
4.3.1.2. Home Healthcare
4.3.1.3. Specialty Clinics
4.3.1.4. Others
4.3.2. BPS Analysis/Market Attractiveness Analysis
4.4. North America Active Wound Care Market Outlook, by Country, Value (US$ Mn), 2018 - 2030
4.4.1. Key Highlights
4.4.1.1. U.S. Active Wound Care Market by Product, Value (US$ Mn), 2018 - 2030
4.4.1.2. U.S. Active Wound Care Market Application, Value (US$ Mn), 2018 - 2030
4.4.1.3. U.S. Active Wound Care Market End User, Value (US$ Mn), 2018 - 2030
4.4.1.4. Canada Active Wound Care Market by Product, Value (US$ Mn), 2018 - 2030
4.4.1.5. Canada Active Wound Care Market Application, Value (US$ Mn), 2018 - 2030
4.4.1.6. Canada Active Wound Care Market End User, Value (US$ Mn), 2018 - 2030
4.4.2. BPS Analysis/Market Attractiveness Analysis
5. Europe Active Wound Care Market Outlook, 2018 - 2030
5.1. Europe Active Wound Care Market Outlook, by Product, Value (US$ Mn), 2018 - 2030
5.1.1. Key Highlights
5.1.1.1. Skin Substitutes
5.1.1.2. Growth Factors
5.1.1.3. Biomaterials
5.2. Europe Active Wound Care Market Outlook, by Application, Value (US$ Mn), 2018 - 2030
5.2.1. Key Highlights
5.2.1.1. Chronic Wounds
5.2.1.2. Acute Wounds
5.3. Europe Active Wound Care Market Outlook, by End User, Value (US$ Mn), 2018 - 2030
5.3.1. Key Highlights
5.3.1.1. Hospitals
5.3.1.2. Home Healthcare
5.3.1.3. Specialty Clinics
5.3.1.4. Others
5.3.2. BPS Analysis/Market Attractiveness Analysis
5.4. Europe Active Wound Care Market Outlook, by Country, Value (US$ Mn), 2018 - 2030
5.4.1. Key Highlights
5.4.1.1. Germany Active Wound Care Market by Product, Value (US$ Mn), 2018 - 2030
5.4.1.2. Germany Active Wound Care Market Application, Value (US$ Mn), 2018 - 2030
5.4.1.3. Germany Active Wound Care Market End User, Value (US$ Mn), 2018 - 2030
5.4.1.4. U.K. Active Wound Care Market by Product, Value (US$ Mn), 2018 - 2030
5.4.1.5. U.K. Active Wound Care Market Application, Value (US$ Mn), 2018 - 2030
5.4.1.6. U.K. Active Wound Care Market End User, Value (US$ Mn), 2018 - 2030
5.4.1.7. France Active Wound Care Market by Product, Value (US$ Mn), 2018 - 2030
5.4.1.8. France Active Wound Care Market Application, Value (US$ Mn), 2018 - 2030
5.4.1.9. France Active Wound Care Market End User, Value (US$ Mn), 2018 - 2030
5.4.1.10. Italy Active Wound Care Market by Product, Value (US$ Mn), 2018 - 2030
5.4.1.11. Italy Active Wound Care Market Application, Value (US$ Mn), 2018 - 2030
5.4.1.12. Italy Active Wound Care Market End User, Value (US$ Mn), 2018 - 2030
5.4.1.13. Turkey Active Wound Care Market by Product, Value (US$ Mn), 2018 - 2030
5.4.1.14. Turkey Active Wound Care Market Application, Value (US$ Mn), 2018 - 2030
5.4.1.15. Turkey Active Wound Care Market End User, Value (US$ Mn), 2018 - 2030
5.4.1.16. Russia Active Wound Care Market by Product, Value (US$ Mn), 2018 - 2030
5.4.1.17. Russia Active Wound Care Market Application, Value (US$ Mn), 2018 - 2030
5.4.1.18. Russia Active Wound Care Market End User, Value (US$ Mn), 2018 - 2030
5.4.1.19. Rest of Europe Active Wound Care Market by Product, Value (US$ Mn), 2018 - 2030
5.4.1.20. Rest of Europe Active Wound Care Market Application, Value (US$ Mn), 2018 - 2030
5.4.1.21. Rest of Europe Active Wound Care Market End User, Value (US$ Mn), 2018 - 2030
5.4.2. BPS Analysis/Market Attractiveness Analysis
6. Asia Pacific Active Wound Care Market Outlook, 2018 - 2030
6.1. Asia Pacific Active Wound Care Market Outlook, by Product, Value (US$ Mn), 2018 - 2030
6.1.1. Key Highlights
6.1.1.1. Skin Substitutes
6.1.1.2. Growth Factors
6.1.1.3. Biomaterials
6.2. Asia Pacific Active Wound Care Market Outlook, by Application, Value (US$ Mn), 2018 - 2030
6.2.1. Key Highlights
6.2.1.1. Chronic Wounds
6.2.1.2. Acute Wounds
6.3. Asia Pacific Active Wound Care Market Outlook, by End User, Value (US$ Mn), 2018 - 2030
6.3.1. Key Highlights
6.3.1.1. Hospitals
6.3.1.2. Home Healthcare
6.3.1.3. Specialty Clinics
6.3.1.4. Others
6.3.2. BPS Analysis/Market Attractiveness Analysis
6.4. Asia Pacific Active Wound Care Market Outlook, by Country, Value (US$ Mn), 2018 - 2030
6.4.1. Key Highlights
6.4.1.1. China Active Wound Care Market by Product, Value (US$ Mn), 2018 - 2030
6.4.1.2. China Active Wound Care Market Application, Value (US$ Mn), 2018 - 2030
6.4.1.3. China Active Wound Care Market End User, Value (US$ Mn), 2018 - 2030
6.4.1.4. Japan Active Wound Care Market by Product, Value (US$ Mn), 2018 - 2030
6.4.1.5. Japan Active Wound Care Market Application, Value (US$ Mn), 2018 - 2030
6.4.1.6. Japan Active Wound Care Market End User, Value (US$ Mn), 2018 - 2030
6.4.1.7. South Korea Active Wound Care Market by Product, Value (US$ Mn), 2018 - 2030
6.4.1.8. South Korea Active Wound Care Market Application, Value (US$ Mn), 2018 - 2030
6.4.1.9. South Korea Active Wound Care Market End User, Value (US$ Mn), 2018 - 2030
6.4.1.10. India Active Wound Care Market by Product, Value (US$ Mn), 2018 - 2030
6.4.1.11. India Active Wound Care Market Application, Value (US$ Mn), 2018 - 2030
6.4.1.12. India Active Wound Care Market End User, Value (US$ Mn), 2018 - 2030
6.4.1.13. Southeast Asia Active Wound Care Market by Product, Value (US$ Mn), 2018 - 2030
6.4.1.14. Southeast Asia Active Wound Care Market Application, Value (US$ Mn), 2018 - 2030
6.4.1.15. Southeast Asia Active Wound Care Market End User, Value (US$ Mn), 2018 - 2030
6.4.1.16. Rest of Asia Pacific Active Wound Care Market by Product, Value (US$ Mn), 2018 - 2030
6.4.1.17. Rest of Asia Pacific Active Wound Care Market Application, Value (US$ Mn), 2018 - 2030
6.4.1.18. Rest of Asia Pacific Active Wound Care Market End User, Value (US$ Mn), 2018 - 2030
6.4.2. BPS Analysis/Market Attractiveness Analysis
7. Latin America Active Wound Care Market Outlook, 2018 - 2030
7.1. Latin America Active Wound Care Market Outlook, by Product, Value (US$ Mn), 2018 - 2030
7.1.1. Key Highlights
7.1.1.1. Skin Substitutes
7.1.1.2. Growth Factors
7.1.1.3. Biomaterials
7.2. Latin America Active Wound Care Market Outlook, by Application, Value (US$ Mn), 2018 - 2030
7.2.1.1. Chronic Wounds
7.2.1.2. Acute Wounds
7.3. Latin America Active Wound Care Market Outlook, by End User, Value (US$ Mn), 2018 - 2030
7.3.1. Key Highlights
7.3.1.1. Hospitals
7.3.1.2. Home Healthcare
7.3.1.3. Specialty Clinics
7.3.1.4. Others
7.3.2. BPS Analysis/Market Attractiveness Analysis
7.4. Latin America Active Wound Care Market Outlook, by Country, Value (US$ Mn), 2018 - 2030
7.4.1. Key Highlights
7.4.1.1. Brazil Active Wound Care Market by Product, Value (US$ Mn), 2018 - 2030
7.4.1.2. Brazil Active Wound Care Market Application, Value (US$ Mn), 2018 - 2030
7.4.1.3. Brazil Active Wound Care Market End User, Value (US$ Mn), 2018 - 2030
7.4.1.4. Mexico Active Wound Care Market by Product, Value (US$ Mn), 2018 - 2030
7.4.1.5. Mexico Active Wound Care Market Application, Value (US$ Mn), 2018 - 2030
7.4.1.6. Mexico Active Wound Care Market End User, Value (US$ Mn), 2018 - 2030
7.4.1.7. Argentina Active Wound Care Market by Product, Value (US$ Mn), 2018 - 2030
7.4.1.8. Argentina Active Wound Care Market Application, Value (US$ Mn), 2018 - 2030
7.4.1.9. Argentina Active Wound Care Market End User, Value (US$ Mn), 2018 - 2030
7.4.1.10. Rest of Latin America Active Wound Care Market by Product, Value (US$ Mn), 2018 - 2030
7.4.1.11. Rest of Latin America Active Wound Care Market Application, Value (US$ Mn), 2018 - 2030
7.4.1.12. Rest of Latin America Active Wound Care Market End User, Value (US$ Mn), 2018 - 2030
7.4.2. BPS Analysis/Market Attractiveness Analysis
8. Middle East & Africa Active Wound Care Market Outlook, 2018 - 2030
8.1. Middle East & Africa Active Wound Care Market Outlook, by Product, Value (US$ Mn), 2018 - 2030
8.1.1. Key Highlights
8.1.1.1. Skin Substitutes
8.1.1.2. Growth Factors
8.1.1.3. Biomaterials
8.2. Middle East & Africa Active Wound Care Market Outlook, by Application, Value (US$ Mn), 2018 - 2030
8.2.1. Key Highlights
8.2.1.1. Chronic Wounds
8.2.1.2. Acute Wounds
8.3. Middle East & Africa Active Wound Care Market Outlook, by End User, Value (US$ Mn), 2018 - 2030
8.3.1. Key Highlights
8.3.1.1. Hospitals
8.3.1.2. Home Healthcare
8.3.1.3. Specialty Clinics
8.3.1.4. Others
8.4. Middle East & Africa Active Wound Care Market Outlook, by Country, Value (US$ Mn), 2018 - 2030
8.4.1. Key Highlights
8.4.1.1. GCC Active Wound Care Market by Product, Value (US$ Mn), 2018 - 2030
8.4.1.2. GCC Active Wound Care Market Application, Value (US$ Mn), 2018 - 2030
8.4.1.3. GCC Active Wound Care Market End User, Value (US$ Mn), 2018 - 2030
8.4.1.4. South Africa Active Wound Care Market by Product, Value (US$ Mn), 2018 - 2030
8.4.1.5. South Africa Active Wound Care Market Application, Value (US$ Mn), 2018 - 2030
8.4.1.6. South Africa Active Wound Care Market End User, Value (US$ Mn), 2018 - 2030
8.4.1.7. Egypt Active Wound Care Market by Product, Value (US$ Mn), 2018 - 2030
8.4.1.8. Egypt Active Wound Care Market Application, Value (US$ Mn), 2018 - 2030
8.4.1.9. Egypt Active Wound Care Market End User, Value (US$ Mn), 2018 - 2030
8.4.1.10. Nigeria Active Wound Care Market by Product, Value (US$ Mn), 2018 - 2030
8.4.1.11. Nigeria Active Wound Care Market Application, Value (US$ Mn), 2018 - 2030
8.4.1.12. Nigeria Active Wound Care Market End User, Value (US$ Mn), 2018 - 2030
8.4.1.13. Rest of Middle East & Africa Active Wound Care Market by Product, Value (US$ Mn), 2018 - 2030
8.4.1.14. Rest of Middle East & Africa Active Wound Care Market Application, Value (US$ Mn), 2018 - 2030
8.4.1.15. Rest of Middle East & Africa Active Wound Care Market End User, Value (US$ Mn), 2018 - 2030
8.4.2. BPS Analysis/Market Attractiveness Analysis
9. Competitive Landscape
9.1. End User vs Application Heatmap
9.2. Manufacturer vs Application Heatmap
9.3. Company Market Share Analysis, 2022
9.4. Competitive Dashboard
9.5. Company Profiles
9.5.1. Smith & Nephew
9.5.1.1. Company Overview
9.5.1.2. Product Portfolio
9.5.1.3. Financial Overview
9.5.1.4. Business Strategies and Development
9.5.2. MiMedx
9.5.2.1. Company Overview
9.5.2.2. Product Portfolio
9.5.2.3. Financial Overview
9.5.2.4. Business Strategies and Development
9.5.3. Tissue Regenix
9.5.3.1. Company Overview
9.5.3.2. Product Portfolio
9.5.3.3. Financial Overview
9.5.3.4. Business Strategies and Development
9.5.4. Organogenesis Inc.
9.5.4.1. Company Overview
9.5.4.2. Product Portfolio
9.5.4.3. Financial Overview
9.5.4.4. Business Strategies and Development
9.5.5. Acell Inc.
9.5.5.1. Company Overview
9.5.5.2. Product Portfolio
9.5.5.3. Financial Overview
9.5.5.4. Business Strategies and Development
9.5.6. Integra Life Sciences
9.5.6.1. Company Overview
9.5.6.2. Product Portfolio
9.5.6.3. Financial Overview
9.5.6.4. Business Strategies and Development
9.5.7. Solsys Medical
9.5.7.1. Company Overview
9.5.7.2. Product Portfolio
9.5.7.3. Financial Overview
9.5.7.4. Business Strategies and Development
9.5.8. Osiris Therapeutics Inc.
9.5.8.1. Company Overview
9.5.8.2. Product Portfolio
v9.5.8.3. Business Strategies and Development
9.5.9. Cytori Therapeutics Inc.
9.5.9.1. Company Overview
9.5.9.2. Product Portfolio
9.5.9.3. Financial Overview
9.5.9.4. Business Strategies and Development
9.5.10. Human BioSciences
9.5.10.1. Company Overview
9.5.10.2. Product Portfolio
9.5.10.3. Financial Overview
9.5.10.4. Business Strategies and Development
10. Appendix
10.1. Research Methodology
10.2. Report Assumptions
10.3. Acronyms and Abbreviations

Companies Mentioned

  • Smith & Nephew
  • MiMedx
  • Tissue Regenix
  • Organogenesis Inc.
  • Acell Inc.
  • Integra Life Sciences
  • Solsys Medical
  • Osiris Therapeutics Inc.
  • Cytori Therapeutics Inc.
  • Human BioSciences
  • Wright Medical Group N.V.

Methodology

Loading
LOADING...